Imvax, Inc.
Biotechnology company · Philadelphia, Pennsylvania, United States
Imvax, Inc. is a biotechnology company headquartered in Philadelphia, Pennsylvania, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $112 million sold in a notice filed in 2020.
Imvax at a glance
What does Imvax do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $112.4 million sold (2020).
Frequently asked questions about Imvax
Where is Imvax headquartered?
Imvax, Inc. is headquartered in Philadelphia, Pennsylvania, United States.
What does Imvax do?
Imvax, Inc. is a biotechnology company.
When was Imvax founded?
The earliest incorporation on record for Imvax, Inc. is in 2015, according to public company registers.
Similar companies
- Spark Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Cabaletta Bio, Inc.Philadelphia, Pennsylvania, United States
- Passage BIO, Inc.Philadelphia, Pennsylvania, United States
- ZSX Medical, LLCPhiladelphia, Pennsylvania, United States
- Enterin, Inc.Philadelphia, Pennsylvania, United States
- Century Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- PolyCore Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Five Eleven Pharma Inc.Philadelphia, Pennsylvania, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences